Dr. Weily Soong has been appointed chief research innovation officer for Dallas-based AllerVie Clinical Research, an affiliate of AllerVie Health and a nationally recognized network of clinical research sites.
Formerly AllerVie’s chief medical officer, Soong will lead efforts at AllerVie Clinical Research to drive innovation with new therapies and diagnostics for asthma, allergies, and other related immunological conditions.
“In his new role, Dr. Soong’s deep understanding of allergy and asthma-related clinical research studies will be invaluable as we continue to grow our company and advance the clinical research field,” AllerVie Health CEO Chris Roussos said in a statement. “I consider his expertise a vital part of our team and an invaluable asset for our patients.”
The public demand is greater than ever for innovative healthcare, excellent customer service, and improved access to these services, the company said. In 2022 alone, AllerVie Health served over 100,000 patients across 12 states with more than 250,000 patient visits.
Advancing therapies, management, and treatment of allergies
“I’m thrilled for the opportunity to work with such a strong team to continue advancing AllerVie’s Clinical Research division forward,” Soong said in a statement. “I’m passionate about the impact clinical research has on patient care, and we are in a time of meaningful advancement in therapies, management, and treatment of allergic and immunologic diseases.”
In addition to his new role with AllerVie Clinical Research, Soong is a physician in AllerVie’s Birmingham practice, formerly known as Alabama Allergy and Asthma Center, where he has worked for nearly 17 years. Soong also is section chief of allergy and immunology for the Birmingham Veterans Administration Medical Center.
Soong completed his Internal Medicine residency at Yale University in New Haven, Connecticut, and remained at Yale for his Allergy and Clinical Immunology Fellowship training.
AllerVie Health is a national network of board-certified allergists and immunologists partnering for the advancement of patient care, serving patients across 12 states in 76 clinic locations.
AllerVie Clinical Research conducts clinical studies in adult and pediatric patients, contributing to the advancement of new therapies for asthma, allergies, and other related immunological conditions while providing access to otherwise unavailable treatments to patients suffering from those conditions.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Pathlock's recent mergers, acquisitions, and capital raises have enabled the company to address the increasing risk in application security while establishing its leadership position as the industry's most complete 360-degree platform for application security and controls automation.
-
Running from March 20-25 on the SMU campus, research and innovation will be on full display.
-
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative. UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
-
Yuvo Health, a New York-based technology-enabled administrative and managed-care solution provider for community health centers, announced Coppell executive Selase Dow as its new chief operating officer. Dow, who will remain based in the Dallas-Fort Worth city, brings more than two decades of managed care experience to the New York startup. Dow has worked closely with large physician organizations in North Texas to implement financial and care models and has a deep background in operations, ACO management, contracting, and more. Yuvo Health is a New York-based startup founded in 2021 by a BIPOC founding team. The company aims to provide administrative…
-
Want to map your innovation-to-market commercialization path or apply for federal money through the $4 billion America's Seed Fund program? Or maybe you're an entrepreneur seeking to validate your customer's needs. The Texas SBDC Technology Commercialization Center wants to help.
